Skip to main content
. 2020 Oct 28;4:PO.20.00200. doi: 10.1200/PO.20.00200

TABLE 3.

Summary of Clinical Outcomes of Patients Treated With Taxane Chemotherapy According to CTC AR-V7 Status After Abiraterone or Enzalutamide and Before Taxane

graphic file with name PO.20.00200t3.jpg